I-Steroids kunye ne-Immunomodulators Inokuphatha i-Facial Psoriasis
I-psoriasis ebusweni, echaphazela kuma-46% abantu abane-psoriasis, ivelisa izikali ze-silvery, i-rashes edibeneyo kwaye, kwiimeko ezinqabileyo, izilonda ezivulekile kwindawo yomzimba onzima ukufihla. Ngenxa yoko, abo abane-psoriasis ebusweni bajongene nemingeni eyahlukeneyo, ebandakanya unyango kunye neendlela zokubhekana nazo
Ukuxilongwa kwe-Facial Psoriasis
Ngenxa yayo kunye neempawu, i-psoriasis ebusweni ayifani neze ne-psoriasis ebonakala kwenye indawo.
Ngaphezu kwakho konke, abantu abane-psoriasis ebusweni banamava afanayo, ama-scaly-shash ephawulekayo nayiphi na uhlobo lwe-psoriasis.
Ukugqithisa ngokuqhelekileyo kuthintela isikhumba ngaphezu komlomo ophezulu, kunye neendawo ezungeze ebunzini nasemacaleni, kunye neenwele. Ngokutsho kwesifundo esisodwa saseKorea sezigulane ezingama-235 ezine-storiasis ebusweni, malunga nabangama-74% abathathi-nxaxheba abaye bahlambalazela ebusweni eliphezulu, kwaye malunga nama-46% ayenomdaka ophakathi kwendlebe. Uphando lwafumanisa ukuba ezininzi izigulane ziqala ukufumana iimpawu zobuso phakathi kweminyaka engama-30 ukuya ku-40.
Ukuze uhlolisise i-psoriasis yobuso, ugqirha uya kuhlola isikhumba somguli kwaye uya kuthatha imbali yakhe yempilo. Ukuba ukuxilongwa kukungathandabuzeki, i-biopsy inokuqhutyelwa ukulawula ezinye izifo zesikhumba, njenge- seborrheic dermatitis .
Izinketho zokwelapha kwi-Facial Psoriasis
Njenge psoriasis eqhelekileyo, i-psoriasis ebusweni ngokubanzi iphendula kakuhle kwi- moisturizers kunye ne-petroleum jelly.
Abantu abane-psoriasis yobuso kufuneka baqwalasele ngokukhawuleza oko kubangela ukuba i- flare-ups , njengoko le mi sebenzi okanye iimveliso kufuneka zigwenywe. Ngokomzekelo, abanye abantu babika ingxelo yokutshiza emva kokubhukuda echibini elichlorisiweyo, ngelixa abanye abantu bathi amanzi achlorine aphucula iimpawu.
Zininzi unyango lwe-steroid ezivunyiweyo zonyango lwe-psoriasis, ezifana ne-hydrocortisone creams, zinokusebenza kakuhle ekuphatheni i-psoriasis ebusweni. Nangona kunjalo, ukusebenzisa i-steroids ezinjalo kufuneka kupheleliswe, njengoko ukusetyenziswa kwexesha elide kunokudala ukunqanda kwesikhumba kunye nezinye iziphumo ezimbi. Xoxa nodokotela wakho malunga nokunyanga kwe-steroid kunye nezinto ezinobungozi.
Iprotopic (i-tacrolimus) , okuyi-immunomodulator, isetyenziswe njengonyango okhutshwayo kwi-facial and genital psoriasis. Iprotopic isistim e-immunosuppressive approved to help prevent the rejection of organs. I-FDA ilumkisa ukuba i-Protopic ayifanele ithathwe njengonyango wokuqala we-psoriasis kunye nokulawula kwayo kufuneka ihlolwe ngokugqithisileyo ngunyango onolwazi. I-arhente yokulawula nayo yalela umenzi ukuba afake ibhokisi elimnyama eli lumkisa ukuba iyeza lixhomekeke engozini yomdlavuza wesikhumba, i-lymphoma, kunye neentsholongwane zentsholongwane. Isilumkiso sebhokisi esimnyama yileyibhile esilumkileyo isilathisi esisebenzayo.
Iprotopic, isetyenziswa ngokuphindwe kabini ngosuku, isebenza ngokuthintela impendulo yomzimba wokucinga okukhuselweyo yomzimba ukucinga ukuba yenza impawu ze-psoriasis. Izigulane ezisetyenziselwa ipropyic maziqhagamshelane nodokotela ngokukhawuleza ukuba zifumana izilonda ezikhukhulayo, umkhuhlane, ukukhathala, izilonda ezibandayo okanye ukugquma kwesikhumba.
Eminye imiphumo engathintekiyo engathintekiyo ingabonakalisa ukuvakalelwa kwesosiza kwisicelo eso, ukubetheka, i-acne, i-nausea, kunye nentloko.
Uphando oluthile luka-2007, olupapashwe kwiBritish Journal of Dermatology , lithelekisa ubungakanani bobabini be-calcitriol kunye ne-tacrolimus. Isifundo seveki ezintandathu, ezibandakanya abathathi-nxaxheba abangama-50 nge-facial or psitalas, bafumana ukuba i-60% yezigulane ezithatha i-tacrolimus zifezekile ngokupheleleyo okanye ziphantse zigqitywe nge-psoriasis kunye nezilonda. Nangona kunjalo, i-33% kuphela yezigulane zisebenzisa i-calcitriol ezinokuphuculwa okufanayo.
Imiba yokuzimelela kunye ne-Facial Psoriasis
Ngenxa yokuba i-psoriasis ebusweni ayilula ukuyifaka okanye i-mask, ihamba nemingeni eyahlukeneyo yengqondo engakhange ijongane nalabo abane-psoriasis engabonakaliyo.
Nangona kunjalo le mingeni iphakanyisiwe, enikezelwa ngokuchanekileyo kunyango kunye nenkxaso.
I-Mayo Clinic icebisa izigulane ukufundisa iintsapho kunye nabahlobo nge-facial psoriasis kunye neendlela zokonyango ezikhuthazwa ngamagqirha. Oku kuvumela ukuba babe yingxenye yesisombululo. Ukufumana iqela lokuxhasa linokukunceda, njengokuba unokuthetha nomcebisi malunga nemiba ephathelene nesi sifo.
Izigulane ezine-psoriasis ebusweni nazo ziyakwazi ukuzama ukujongana neziganeko ezihlukeneyo. I-National Psoriasis Foundation ikhuthaza iDermablend, izimonyo ezenzelwe abantu abane-psoriasis, i-dermatitis kunye nezinye iimeko zesikhumba. Nangona kunjalo, isiseko siluleko malunga nokusebenzisa izimonyo kwi-sikhumba esicasulayo ngokugqithiseleyo okanye izilonda ezingavulwanga, kuba oku kungabangela ukutshatyalaliswa nokutshatyalazwa.
Imithombo:
"I-American Academy yeDermatology iphendula kwisigqibo se-FDA kwiMicrothem ye-Eczema." I-American Academy yeDermatology. 19 JAN 2006. I-American Academy yeDermatology.
"I-Calcipotriene Topical." I-MedlinePlus Iinkcukacha Zeziyobisi. 2008. Iziko lezeMpilo zeSizwe.
"Calcitriol." I-MedlinePlus Iinkcukacha Zeziyobisi. 2007. Iziko lezeMpilo zeSizwe.
Fortune, DG, HL Richards, CJ Main, kunye neCEM Griffiths. "Amagqabantshintshi eZiGulane zokuSingatha i-Psoriasis." Dermatological Clinic. 27. 3. Meyi 2002. 177-184.
"I-Hydrocortisone Topical." I-MedlinePlus Iinkcukacha Zeziyobisi . 2007. Iziko lezeMpilo zeSizwe.
Liao, YH, HC Chiu, YS Tseng, kunye neTF Tsai. "Ukuthelekiswa kokunyamezela kunye nokusebenza kweCalcitriol 3 I-Microg g (-1) i-Ointment kunye neTacrolimus 0.3 mg g (-1) Iigcoba kwi-Plaque Psoriasis engapheliyo ebandakanyekayo kwiindawo ezijongene nobuso okanye i-Genitofemoral: I-Trial-Blind. I-British Journal yeDermatology. 157. 5. NgoNovemba 2007. 1005-12.
"Ukuphila nge-Psoriasis: Ukufihla kunye ne-Cover-ups". I-National Psoriasis Foundation: Inkomfa kunye ne-cover-ups . 2008. iNational Psoriasis Foundation.
Abasebenzi beKliniki yabasebenzi. "I-Psoriasis: Ukujongana Nezakhono." Mayo Clinic.com . 20 uMatshi 2007. I-Clinical Mayo.
"Iphepha leNgcaciso yoMguli: I-Tacrolimus Oil." Iziko loVavanyo lweMida noPhando . NgoMeyi 2006. Ukutya kunye noLawulo lweeMithi.
"I-Psoriasis kwiSayithi eziKhuselweyo eziNgcini: i-Psoriasis kwi-Face." I-National Psoriasis Foundation: i-Psoriasis kwi-Face . Ngo-Oktobha 2005. iSiseko seSizwe sePororiasis.
UVan de Kerkhof, iComputer, GM Murphy, J. Austad, A. Ljungberg, F. Cambazard kunye noLB Duvold. "I-Psoriasis ye-Face and Flexures." Umbhalo we-Dermatological Treatment. 18. 6. 2007. 351-360.
Yoon, HS, JY Park, kunye noJL Youn. "Isifundo seKliniki ye-Facial Psoriasis." Ingxelo yeKorea yeDermatology. 44. 12. Ngomhla ka-2006. 1397-1402.